Vittarthaa’s current therapeutic areas are Urea cycle disorder and gout. Pharmaceutical compounds are designed, patented and ready for assessment in preclinical development (DMPK*, POC** and safety).
We are open for discussion on Drug Development strategies and Business Models for development of Patented Pharmaceuticals Compounds for Urea Cycle Disorder (UCD) and Gout.
Vittarthaa aims to develop these programs with partners who can provide appropriate business model that accelerate regulatory approval paths.
* Drug Metabolism and Pharmacokinetics; ** proof-of-concept